Finasteride Tablet, Coated
Product Images NDC 67877-455

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 67877-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Finasteride 30t

Finasteride 30t
Label for Finasteride Tablets, USP 1 mg oral coated tablets by Ascend Laboratories, LLC. The label indicates 30 tablets per package and includes warnings against use by women or children, especially pregnant women. Storage instructions specify 20° to 25°C (68° to 77°F), and it mentions packaging details and barcode. The product is prescription only.*
FDA Label Image

Finasteride 500t

Finasteride 500t
Label for Finasteride Tablets, USP 1 mg oral coated tablets. The label includes dosage and storage instructions, a warning against use by women or children, and manufacturer and distributor information. The product is supplied by Ascend Laboratories, LLC and contains 500 tablets per package. The design includes a barcode and areas specified for UV varnish application.*
FDA Label Image

Finasteride 90t

Finasteride 90t
Finasteride Tablets, USP 1 mg coated tablets in a 90-tablet package by Ascend Laboratories, LLC. The label includes dosage instructions, storage conditions (20° to 25°C), and a warning against use by women or children and pregnant women. It also features the NDC 67877-455-90, manufacturer and distributor information, and a barcode.*
FDA Label Image

Finasteride-figure1 (Finasteride Figure1)

Finasteride-figure1 (Finasteride Figure1)
A line graph titled "Effect on Hair Count" showing the mean change in number of hairs within a 1-inch diameter circle over time from baseline. The x-axis represents time in months for the first year and years thereafter up to 5 years. The y-axis shows mean change in hair count ranging from -275 to 125. Four groups are plotted comparing finasteride 1 mg and placebo with varying dosing regimens, with pooled data from vertex hair loss studies. The graph includes sample sizes for each group at different time points.*
FDA Label Image

Finasteride-structure (Finasteride Structure)

Finasteride-structure (Finasteride Structure)
Chemical structure of finasteride, showing its multi-ring steroid framework with attached functional groups including a ketone and a tertiary amide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.